日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting DESI2 as a Novel Therapeutic Strategy for JAK2-Mutant Leukemias

以DESI2为靶点治疗JAK2突变型白血病的新型治疗策略

Mei, Husheng; Wen, Wuqiang; Zhang, Wenjun; Zhang, Shujing; Sun, Ting; Li, Guiming; Zhang, Jing; Qi, Shuang; Zhou, Jie; Li, Bing; Zhao, Yunshuo; Chen, Xiaotong; Li, Bowen; Xue, Yiying; Lu, Wang; Sun, Yanli; Wang, Jingyao; Shan, Hengyue; Zhang, Shengzhe; Huang, Yushan; Chen, Yisa; Wang, Wenchao; Liu, Qingsong; Lu, Wenchao; Tan, Li; Ding, Yi; Fu, Jianfei; Long, Jun; Zhang, Lei; Zhao, Baobing; Liang, Aibin; Jiang, Baishan; Yang, Jing

Ubiquitin-specific protease 7-mediated stabilization of discoidin domain receptor 1 drives progression of TP53-Mutant cancers.

泛素特异性蛋白酶 7 介导的盘状结构域受体 1 的稳定作用驱动 TP53 突变癌症的进展

Xue Yiying, Xiu Bing, Yang Muye, Zhang Yanwei, Yang Changpeng, Zhang Lele, Yan Yilv, Luo Xiu, Huang Yushan, Mei Husheng, Li Guiming, Zhou Lixin, Chen Yisa, Zhang Wenjun, Qian Changlin, Zhang Peng, Liu Juan, Liang Aibin, Zeng Yu, Yang Jing

Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS-CoV-2

利用临床上已有的药物和疗法对抗SARS-CoV-2的致病靶点

Xue, Yiying; Mei, Husheng; Chen, Yisa; Griffin, James D; Liu, Qingsong; Weisberg, Ellen; Yang, Jing